Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 208,000 | 287,000 | 188,000 | 210,000 | 195,000 |
| Receivables | 1,587,000 | 1,580,000 | 1,548,000 | 1,470,000 | 1,444,000 |
| Inventories | 1,087,000 | 1,113,000 | 1,078,000 | 1,077,000 | 1,023,000 |
| Income taxes - deferred | N/A | 50,000 | N/A | 76,000 | 75,000 |
| Other current assets | 1,001,000 | 1,050,000 | 942,000 | 645,000 | 485,000 |
| TOTAL | $3,929,000 | $4,080,000 | $3,822,000 | $3,478,000 | $3,222,000 |
| Non-Current Assets | |||||
| PPE Net | 1,715,000 | 1,700,000 | 1,697,000 | 1,678,000 | 1,651,000 |
| Intangibles | 13,176,000 | 12,697,000 | 12,835,000 | 12,665,000 | 12,792,000 |
| Other Non-Current Assets | 796,000 | 725,000 | 688,000 | 815,000 | 717,000 |
| TOTAL | $15,687,000 | $15,122,000 | $15,220,000 | $15,158,000 | $15,160,000 |
| Total Assets | $19,615,000 | $19,202,000 | $19,042,000 | $18,636,000 | $18,382,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,685,000 | 962,000 | 1,801,000 | 1,266,000 | 1,018,000 |
| Accounts payable and accrued liabilities | 403,000 | 404,000 | 530,000 | 371,000 | 376,000 |
| Accrued Expenses | 2,266,000 | 2,447,000 | 2,456,000 | 2,551,000 | 2,238,000 |
| Other current liabilities | 399,000 | 1,174,000 | 867,000 | 640,000 | 668,000 |
| TOTAL | $4,753,000 | $4,988,000 | $5,654,000 | $4,828,000 | $4,300,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,808,000 | 4,803,000 | 3,815,000 | 4,416,000 | 4,817,000 |
| Other Non-Current Liabilities | 1,945,000 | 2,254,000 | 2,370,000 | 1,738,000 | 1,972,000 |
| TOTAL | $7,117,000 | $7,185,000 | $6,376,000 | $6,220,000 | $6,847,000 |
| Total Liabilities | $11,871,000 | $12,172,000 | $12,030,000 | $11,048,000 | $11,147,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,382,925 | 1,379,811 | 1,374,911 | 1,373,196 | 1,372,127 |
| Common Shares | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 |
| Retained earnings | -7,770,000 | -8,326,000 | -8,390,000 | -7,785,000 | -8,068,000 |
| Other shareholders' equity | -16,000 | -127,000 | -58,000 | -51,000 | -53,000 |
| TOTAL | $7,744,000 | $7,030,000 | $7,012,000 | $7,588,000 | $7,235,000 |
| Total Liabilities And Equity | $19,615,000 | $19,202,000 | $19,042,000 | $18,636,000 | $18,382,000 |